IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

PFM Health Sciences, LP

Q2 2018 Holdings

Filed 2018-08-14 | 122 holdings | $240.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Mylan N VSHS EURON59465109$161.9K4,480,7200.1%
Anthem Inc(ELV)COM036752103$168.3K707,2440.1%
Aerie Pharmaceuticals Inc(AERIEUR)COM00771V108$183.8K2,720,2180.1%
Portola Pharmaceuticals IncCOM737010108$191.9K5,079,7700.1%
Ishares TR(IWM)PutRUSSELL 2000464287655$203.0K1,239,3000.1%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$213.5K1,238,9060.1%
Invesco QQQ TR(QQQ)PutUNIT SER 146090E103$411.8K2,398,9000.2%
BOX Inc(BOX)CL A10316T104$1.3M50,3590.5%
Autolus Therapeutics PLC(AUTL)SPON ADS05280R100$5.3M197,8742.2%
Arcus Biosciences Inc(RCUS)COM03969F109$9.4M768,2793.9%
Accuray Inc(ARAY)COM004397105$20.7M5,050,5708.6%
Cirrus Logic Inc(CRUS)COM172755100$29.0M756,54612.1%
Boston Scientific Corp(BSX)COM101137107$43.1M1,317,12017.9%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$51.8M614,50621.5%
Alibaba Group Hldg LTD(BABA)SPONSORED ADS01609W102$73.8M397,78630.7%
PreviousPage 3 of 3